Profile: Migenix Inc. specializes in developing drugs for the prevention and treatment of major medical diseases & certain conditions with unmet medical need. Our MX-3253 celgosivir is a novel, oral antiviral agent under development for the treatment of chronic Hepatitis C Virus (HCV) infection. Our MX-226 is a novel, topical antibiotic for the prevention of catheter-related infections. Our MX-594AN is a novel, topical antibiotic for the treatment of acne.